TABLE 1.
Interaction between vitamin B-12 status and serum folate in relation to anemia and cognitive impairment among nonexcluded senior participants in the National Health and Nutrition Examination Survey (1999–2002) (31)
Vitamin status |
|||||||
Outcome | B-121 | Folate2 | No. of Subjects | Percentage with outcome | OR (95% CI) | OR (95% CI) | OR (95% CI) |
Anemia | Normal | Normal | 913 | 3.5 | 1.0 | 1.0 | 1.0 |
Normal | High | 198 | 2.5 | 0.5 (0.2, 1.8) | 0.6 (0.2, 2.5) | 0.7 (0.2, 2.5) | |
Low | Normal | 297 | 6.9 | 1.6 (1.02, 2.6) | 2.1 (1.1, 3.8) | 1.9 (0.99, 3.7) | |
Low | High | 49 | 15 | 5.1 (2.1, 8.0) | 5.2 (2.5, 11.0) | 5.0 (2.4, 10.6) | |
Cognitive impairment | Normal | Normal | 826 | 18 | 1.0 | 1.0 | 1.0 |
Normal | High | 180 | 11 | 0.4 (0.2, 0.7) | 0.4 (0.2, 0.9) | 0.5 (0.2, 0.96) | |
Low | Normal | 253 | 25 | 1.6 (0.99, 2.4) | 1.7 (1.01, 2.9) | 1.5 (0.9, 2.5) | |
Low | High | 42 | 45 | 4.3 (2.3, 8.0) | 5.1 (2.7, 9.5) | 4.7 (2.5, 8.7) |
Low serum vitamin B-12 < 148 pmol/L or serum methylmalonic acid above reference range (ie, 60–210 nmol/L) for vitamin B-12–replete participants with normal serum creatinine.
High serum folate > 59 nmol/L (80th percentile).